Martingale Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-28,914
| Closed | -$806K | – | 906 |
|
|
2021
Q3 | $806K | Buy |
28,914
+21,500
| +290% | +$599K | 0.01% | 558 |
|
|
2021
Q2 | $220K | Buy |
+7,414
| New | +$220K | ﹤0.01% | 784 |
|
|
2020
Q4 | – | Sell |
-74,713
| Closed | -$1.88M | – | 1063 |
|
|
2020
Q3 | $1.88M | Sell |
74,713
-50,498
| -40% | -$1.27M | 0.02% | 439 |
|
|
2020
Q2 | $3.06M | Buy |
+125,211
| New | +$3.06M | 0.04% | 421 |
|